Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211.SZ) SHZ

15.16

+0.26(+1.74%)

Updated at November 14 12:37PM

Currency In CNY

Valuation

Market Cap4.22B
Enterprise Value3.7B
P/E Ratio93.83
PEG Ratio-2.7
Price/Sales Ratio9.92
Price/Book Ratio1.73
Enterprise/Revenue8.7
Enterprise/EBITDA79.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.09

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue445.86M
Revenue/Share1.7
Gross Profit128.59M
EBITDA126.16M
Net Income91.55M
Diluted EPS0.32

Balance Sheet

Total Cash1.57B
Total Cash/Share6.08
Total Debt2.38M
Total Debt/Equity0
Current Ratio14.79
Book Value Per Share8.74

Price History

52-Week Change-2.07
52-Week High17.14
52-Week Low9.38
Moving Average 50 Days12.94
Moving Average 200 Days12.45

Statistics

Average Volume11.09M
Shares Outstanding288M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield1.65
Payout Ratio1.73
Last Split Factor29:20
Last Split DateAugust 27, 2025